Cargando…
The utility of biomarkers in acute GVHD prognostication
Autores principales: | Spyrou, Nikolaos, Akahoshi, Yu, Ayuk, Francis, Holler, Ernst, Choe, Hannah, Etra, Aaron, Hogan, William J., Rösler, Wolf, Hexner, Elizabeth, DeFilipp, Zachariah, Reshef, Ran, Chanswangphuwana, Chantiya, Qayed, Muna, Kraus, Sabrina, Eder, Matthias, Javorniczky, Nora Rebeka, Grupp, Stephan A., Kitko, Carrie L., Merli, Pietro, Aguayo-Hiraldo, Paibel, Wölfl, Matthias, Baez, Janna, Beheshti, Rahnuma, Eng, Gilbert, Gleich, Sigrun, Katsivelos, Nikolaos, Khan, Alina, Kowalyk, Steven, Morales, George, Young, Rachel, Nakamura, Ryotaro, Chen, Yi-Bin, Levine, John E., Ferrara, James L. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10480526/ https://www.ncbi.nlm.nih.gov/pubmed/37142257 http://dx.doi.org/10.1182/bloodadvances.2023009929 |
Ejemplares similares
-
Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD
por: Akahoshi, Yu, et al.
Publicado: (2023) -
Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease
por: Al Malki, Monzr M., et al.
Publicado: (2023) -
Assessment of systemic and gastrointestinal tissue damage biomarkers for GVHD risk stratification
por: Etra, Aaron, et al.
Publicado: (2022) -
Disease Risk and GVHD Biomarkers Can Stratify Patients For Risk of Relapse and Non-Relapse Mortality Post Hematopoietic Cell Transplant
por: Aziz, Mina D., et al.
Publicado: (2020) -
Clinical characteristics of oral chronic graft-versus-host disease according to the 2014 National Institutes of Health (USA) consensus criteria
por: Pengpis, Nawaporn, et al.
Publicado: (2023)